CLXTのチャート
CLXTの企業情報
symbol | CLXT |
---|---|
会社名 | Calyxt Inc (カリクスト) |
分野(sector) | Basic Industries 素材 |
産業(industry) | Agricultural Chemicals |
業種 | 漁業_農業 一般消費財(Consumer Products) |
概要 | 事業概要 カリックス(Calyxt Inc.)は食品と農業会社である。同社は、消費者及び農家に対する除草剤耐性などの農業的に有利な作物特性向けに、より健康的な油と高繊維小麦などの専門食材を提供する。同社はまた、植物ゲノムを編集して所望の形質および特性を引き出すことを可能にする遺伝子編集技術および技術を組み合わせている。同社の製品には、コンシューマー・セントリック製品とファーマー・セントリック製品が含まれる。コンシューマーセンター製品は高オレイン酸大豆、高繊維小麦、高繊維小麦II、還元グルテン小麦、冷蔵保存可能ジャガイモおよび還元褐変ジャガイモを含む。ファーマー・セントリック製品は干ばつ耐性大豆、改良大豆、除草剤耐性小麦、除草剤耐性キャノーラ、除草剤耐性アルファルファおよび除草剤品質アルファルファを含む。同社は、高オレイン酸大豆、ウドンコ病抵抗性コムギおよび冷蔵保存可能なジャガイモを含むいくつかの製品を開発中である。 カリクストは米国の農産物食品企業。健康に焦点を当てた農産物を消費者に提供し、除草剤耐性のある農作物などの開発を生産農家に提供する。同社の遺伝子編集技術は植物ゲノムを正確に編集し、高繊維小麦や健康志向の油を開発するなど、外来のDNAを含まずに植物本来の形質や特性を引き出す技術に特化する。本社所在地はマサチュ―セッツ州ブライトン。 |
本社所在地 | 2800 Mount Ridge Road Roseville MN 55113-1127 USA |
代表者氏名 | Andre Choulika アンドレ・チュリカ |
代表者役職名 | Chairman of the Board 取締役会会長 |
電話番号 | +1 651-683-2807 |
設立年月日 | 40179 |
市場名 | NASDAQ National Market System |
ipoyear | 2017年 |
従業員数 | - |
url | www.calyxt.com |
nasdaq_url | https://www.nasdaq.com/symbol/clxt |
adr_tso | ― |
EBITDA | EBITDA(百万ドル) -30.89400 |
終値(lastsale) | 14.23 |
時価総額(marketcap) | 460288631.65 |
時価総額 | 時価総額(百万ドル) 401.74170 |
売上高 | 売上高(百万ドル) 0.43700 |
企業価値(EV) | 企業価値(EV)(百万ドル) 313.56570 |
当期純利益 | 当期純利益(百万ドル) -31.69900 |
決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Calyxt Inc revenues decreased 26% to $207K. Net loss increased 92% to $11.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Sales general and administrative increase from $3.2M to $6.5M (expense) Stock-based Compensation in SGA increase from $425K to $1.3M (expense). |
CLXTのテクニカル分析
CLXTのニュース
Calyxt stockholders approve merger and reverse stock split; anticipated name change and ticker symbol for combined company 2023/05/19 20:31:15 Seeking Alpha
Calyxt (CLXT) held a special meeting of its stockholders on May 18, where stockholders voted in favor of all proposals, including the issuance of shares of Class A and Class B common…
Calyxt GAAP EPS of -$1.09, revenue of $0.04M 2023/05/01 20:53:57 Seeking Alpha
Calyxt press release (CLXT): Q1 GAAP EPS of -$1.09.Revenue of $0.04M (+33.3% Y/Y).Cash and cash equivalents totaled $2.1 million as of March 31, 2023.Total operating expenses were…
Calyxt: Q1 Earnings Snapshot 2023/05/01 20:07:24 WTOP
ROSEVILLE, Minn. (AP) — ROSEVILLE, Minn. (AP) — Calyxt Inc. (CLXT) on Monday reported a loss of $5.4 million in…
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update 2023/05/01 20:01:00 PR Newswire
Proposed merger with Cibus Global Expected to Close in Q2 2023 1-for-10 reverse stock split executed Current customer projects under development are on track Evologic Technologies completed initial phase of project to scale production of Calyxt''s Plant Cell Matrix and BioFactoryTM…
Calyxt Announces Effective Date of Reverse Stock Split 2023/04/07 20:05:00 PR Newswire
ROSEVILLE, Minn., April 7, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced that it will proceed with the 1-for-10 reverse stock split previously approved by the Company''s shareholders at the annual meeting of shareholders on June 1, 2022….
Calyxt Announces Effective Date of Reverse Stock Split 2023/04/07 20:05:00 PR Newswire
ROSEVILLE, Minn., April 7, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced that it will proceed with the 1-for-10 reverse stock split previously approved by the Company''s shareholders at the annual meeting of shareholders on June 1, 2022….
Steady Stocks: Calyxt, Inc. (NASDAQ:CLXT -1.28%), IMV Inc. (NASDAQ:IMV 1.46%) 2023/03/09 19:17:02 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Steady Stocks: Calyxt, Inc. (NASDAQ:CLXT -1.28%), IMV Inc. (NASDAQ:IMV 1.46%) appeared first on Stocks Equity .
Volume Movers: Calyxt, Inc. (NASDAQ:CLXT -18.16%), Amesite Inc. (NASDAQ:AMST 0.32%) 2023/03/09 12:44:30 Stock Equity
Calyxt, Inc. (NASDAQ:CLXT) with the stream of -18.16% also noticed, India Amesite Inc. (NASDAQ:AMST) encountered a rapid change of 0.32% in the last hour of Wednesday’s trading session. On 08-03-2023, … The post Volume Movers: Calyxt, Inc. (NASDAQ:CLXT -18.16%), Amesite Inc. (NASDAQ:AMST 0.32%) appeared first on Stocks Equity .
Calyxt GAAP EPS of -$0.06, revenue of $0.04M 2023/03/06 22:05:26 Seeking Alpha
Calyxt press release (CLXT): Q4 GAAP EPS of -$0.06.Revenue of $0.04M (-97.9% Y/Y).Cash, cash equivalents, and restricted cash totaled $3.5 million as of December 31, 2022.
Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update 2023/03/06 21:30:00 GlobeNewswire
NEW YORK, 06 mars 2023 (GLOBE NEWSWIRE) -- Cellectis S.A. (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company for which Cellectis owns 49.1% (as of December 31, 2022) of its issued and outstanding common stock, today announced operating and financial results for its fourth quarter ended December 31, 2022. The contents of Calyxt’s announcement are included below:
Calyxt Switches Gears Again, But The Cash Clock Keeps Ticking Down 2022/04/01 06:18:39 Seeking Alpha
78 Biggest Movers From Yesterday 2022/03/11 09:22:39 Benzinga
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC ) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday. AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI ) gained 102.4% to close at $3.42 after the company announced a binding letter of intent to acquire Deroose Planta NV. Enservco Corporation (NYSE: ENSV ) shares jumped 43.1% to close at $4.32 after dropping 28% on Wednesday. Hoth Therapeutics, Inc. (NASDAQ: HOTH ) gained 38.8% to close at $0.7968 following circulation of an FDA AccessData.gov listing which showed the company''s c-KIT-targeting candidate received orphan-drug designation. AquaBounty Technologies, Inc. (NASDAQ: AQB ) surged 37.8% to close at $1.93 after the company reported FY21 EPS results were higher year over year. Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX ) jumped 33.4% to close at $0.50. Almaden Minerals Ltd. (NYSE: AAU ) gained 32.9% to settle at $0.4480. Ebix, Inc. (NASDAQ: EBIX ) jumped 31.4% to settle at $41.90 on Thursday. The company recently posted upbeat quarterly sales.